Skobe M - Search Results

1

Pepper MS, Tille JC, Nisato R, Skobe M. Pepper MS, et al. Among authors: skobe m. Cell Tissue Res. 2003 Oct;314(1):167-77. doi: 10.1007/s00441-003-0748-7. Epub 2003 Jul 18. Cell Tissue Res. 2003. PMID: 12883995 Review.

2

Lymphatic endothelium: morphological, molecular and functional properties.

Pepper MS, Skobe M. Pepper MS, et al. Among authors: skobe m. J Cell Biol. 2003 Oct 27;163(2):209-13. doi: 10.1083/jcb.200308082. J Cell Biol. 2003. PMID: 14581448 Free PMC article. Review.

3

Molecular characterization of lymphatic endothelial cells.

Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M. Podgrabinska S, et al. Among authors: skobe m. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16069-74. doi: 10.1073/pnas.242401399. Epub 2002 Nov 22. Proc Natl Acad Sci U S A. 2002. PMID: 12446836 Free PMC article.

4

Lymphatic function, lymphangiogenesis, and cancer metastasis.

Swartz MA, Skobe M. Swartz MA, et al. Among authors: skobe m. Microsc Res Tech. 2001 Oct 15;55(2):92-9. doi: 10.1002/jemt.1160. Microsc Res Tech. 2001. PMID: 11596154 Review.

5

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.

Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Skobe M, et al. Nat Med. 2001 Feb;7(2):192-8. doi: 10.1038/84643. Nat Med. 2001. PMID: 11175850

6

Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin.

Goldman J, Le TX, Skobe M, Swartz MA. Goldman J, et al. Among authors: skobe m. Circ Res. 2005 Jun 10;96(11):1193-9. doi: 10.1161/01.RES.0000168918.27576.78. Epub 2005 May 12. Circ Res. 2005. PMID: 15890974

7

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.

Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. Skobe M, et al. Am J Pathol. 2001 Sep;159(3):893-903. doi: 10.1016/S0002-9440(10)61765-8. Am J Pathol. 2001. PMID: 11549582 Free PMC article.

8

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, Pytowski B, Skobe M. Roberts N, et al. Among authors: skobe m. Cancer Res. 2006 Mar 1;66(5):2650-7. doi: 10.1158/0008-5472.CAN-05-1843. Cancer Res. 2006. PMID: 16510584

9

Therapeutic lymphangiogenesis with human recombinant VEGF-C.

Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG. Szuba A, et al. Among authors: skobe m. FASEB J. 2002 Dec;16(14):1985-7. doi: 10.1096/fj.02-0401fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397087

10

Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.

Das S, Ladell DS, Podgrabinska S, Ponomarev V, Nagi C, Fallon JT, Skobe M. Das S, et al. Among authors: skobe m. Cancer Res. 2010 Mar 1;70(5):1814-24. doi: 10.1158/0008-5472.CAN-09-3675. Epub 2010 Feb 23. Cancer Res. 2010. PMID: 20179201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page